Totsune K, Takahashi K, Murakami O, Satoh F, Sone M, Saito T, Sasano H, Mouri T, Abe K
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Hypertension. 1994 Dec;24(6):758-62. doi: 10.1161/01.hyp.24.6.758.
We studied the presence of three natriuretic peptides--atrial natriuretic peptide (ANP), human brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP)--in the human kidney by radioimmunoassay and immunocytochemistry. Immunoreactive ANP, immunoreactive human BNP, and immunoreactive CNP concentrations in six kidneys were 0.12 +/- 0.07 (mean +/- SD), 0.23 +/- 0.08, and 0.37 +/- 0.07 pmol/g wet wt, respectively. Sephadex G-50 superfine column chromatography and reversed-phase high-performance liquid chromatography of kidney extracts revealed a broad peak of immunoreactive ANP comigrating with ANP-28 and urodilatin. Renal immunoreactive human BNP consisted of three components; the major component comigrated with human BNP-32. Renal immunoreactive CNP consisted of at least two components; the major component comigrated with CNP-22, and the minor component eluted in a position similar to that of authentic human CNP-53. Immunocytochemistry showed that immunoreactive human BNP was colocalized with immunoreactive ANP in the segments of distal tubules, whereas immunoreactive CNP was found predominantly in the proximal tubules. These findings indicate that these three natriuretic peptides are present in the human kidney and raise the possibility that they form a renal natriuretic peptide system that participates in the local regulation of sodium and water transport and renal circulation in the human kidney.
我们通过放射免疫分析和免疫细胞化学方法研究了三种利钠肽——心房利钠肽(ANP)、人脑利钠肽(BNP)和C型利钠肽(CNP)——在人肾脏中的存在情况。六个肾脏中免疫反应性ANP、免疫反应性人脑BNP和免疫反应性CNP的浓度分别为0.12±0.07(平均值±标准差)、0.23±0.08和0.37±0.07 pmol/g湿重。肾脏提取物的葡聚糖G-50超细柱色谱和反相高效液相色谱显示,一个与ANP-28和尿舒张素共迁移的免疫反应性ANP宽峰。肾脏免疫反应性人脑BNP由三种成分组成;主要成分与人脑BNP-32共迁移。肾脏免疫反应性CNP至少由两种成分组成;主要成分与CNP-22共迁移,次要成分在与真实人脑CNP-53相似的位置洗脱。免疫细胞化学显示,免疫反应性人脑BNP与免疫反应性ANP在远曲小管段共定位,而免疫反应性CNP主要存在于近曲小管。这些发现表明,这三种利钠肽存在于人肾脏中,并增加了它们形成一个参与人肾脏钠和水转运及肾循环局部调节的肾利钠肽系统的可能性。